Format

Send to

Choose Destination
AIDS Behav. 2018 Apr;22(4):1329-1340. doi: 10.1007/s10461-017-1836-0.

Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.

Author information

1
Department of Infectious Disease Epidemiology, Imperial College London, Norfolk place, London, W21PG, UK. Tavitianexley@gmail.com.
2
Department of Infectious Disease Epidemiology, Imperial College London, Norfolk place, London, W21PG, UK. mc.boily@imperial.ac.uk.
3
Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, USA.
4
Faculty of Medicine, University of Tartu, Tartu, Estonia.
5
NGO Stellit, St Petersburg, Russian Federation.
6
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Canada.

Abstract

Non-medical drug injection is a major risk factor for HIV infection in Russia and Estonia. Multiple drug use (polydrug) has further been associated with increased harms. We compared HIV, injecting and sexual risk associated with polydrug use among people who injected drugs (PWID) in 2012-2013 in Kohtla-Järve (Estonia, n = 591) and St Petersburg (Russia, n = 811). Using latent class analysis, we identified five (poly)drug classes, the largest consisting of single-drug injectors among whom an opioid was the sole drug injected (56% of PWID). The four remaining polydrug classes included polydrug-polyroute injectors who injected and used opiates and stimulants (9%), opiate-stimulant poly-injectors who injected amphetamine-type-stimulants with a primary opiate (7%) and opiate-opioid poly-injectors who injected opioids and opiates (16%). Non-injection stimulant co-users were injectors who also used non-injection stimulants (12%). In multivariable multinomial regressions, all four polydrug classes were associated with greater injection risks than single-drug injection, while opiate-stimulant and opiate-opioid poly-injection were also associated with having multiple sex partners. Riskier behaviours among polydrug-injectors suggest increased potential for transmission of blood-borne and sexually-transmitted infections. In addition to needles/syringes provision, services tailored to PWID drug and risk profiles, could consider drug-appropriate treatment and sexual risk reduction strategies to curb HIV transmission.

KEYWORDS:

Amphetamines; Eastern Europe; HIV; Heroin/opioid; Latent class analysis; People who inject drugs; Polydrug use; Risk behaviours

PMID:
28699018
PMCID:
PMC5878835
DOI:
10.1007/s10461-017-1836-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center